businessbriefs
SubjectsAll subjects on briefs.cloud →
Saved
Companies

Corteva

2018

Corteva is not a startup—it’s DowDuPont’s agriculture division, spun off to sell more chemicals while pretending to pivot away from them.

Worth your time?3.5/5Yes.Study the whole thing.What works, what does not, who it is for ↓
11:18in productionCh. 1 · Not a startup. A spin-off./ 11:18 · ceiling 15 min
4 chapters · 11:18Ceiling 15:00

The brief is written and checked. The video joins this page when it is cut.4 chapters · 1 min read · 11:18 planned

Read the brief

Corteva is a post-merger agricultural platform—neither innovative nor disruptive, but operationally disciplined. It monetises legacy chemistry while layering biologicals and biofuels as defensive growth vectors. Its real constraint is not R&D capacity, but regulatory tolerance for animal testing and neurotoxic pesticides.

CompaniesAgricultureChemistrySupply chainsAgriculture across the network →
Chapters & takeaways4
  1. 1:05
    Not a startup. A spin-off.

    Corteva is a corporate carve-out—not a founder-led venture—but a legally distinct entity built to monetise DowDuPont’s agricultural IP.

  2. 2:42
    Testing beagles while retiring chlorpyrifos

    It commissions animal testing while phasing out one neurotoxic pesticide—showing regulatory compliance and reputational management, not systemic reform.

  3. 4:54
    Biologicals by acquisition, not invention

    Its $1.2 billion acquisition of Stoller Group signals a real bet on biologicals—but only as an additive, not a replacement, to its chemical portfolio.

  4. 6:48
    Two strategies, one balance sheet

    Its 2025 fungicide launch and 2024 BP biofuel deal reveal parallel tracks: defending core chemistry markets while seeking low-carbon adjacency.

1 more chapterFewer chapters
Worth your time?

Yes. Study the whole thing.

3.5/ 5
What works
  • business/companies
  • business/strategy
  • business/product
What does not
  • business/startups-and-venture
  • business/founders
  • business/ideas
Study it if
  • investors
  • regulators
  • agribusiness procurement teams
Skip it if
  • consumers
  • activists
  • students of innovation
Who should study it, and who should skipHide who it is for
The written brief1 min read

What the company or idea is

Corteva is a U.S.-based public company formed in March 2018 as DowDuPont’s agriculture subsidiary, focused exclusively on seeds and crop protection.

How it actually makes money

Corteva makes money selling seeds and crop protection products—including herbicides, insecticides, fungicides, and biologicals—in 110 countries.

What works

Its acquisition strategy works: the $1.2 billion purchase of Stoller Group and Symborg expanded its biologicals portfolio credibly, and its BP partnership signals credible downstream diversification beyond field crops.

What does not

Its public narrative of sustainability does not align with its commissioning of beagle testing in 2019 or its continued reliance on synthetic fungicides like flutriafol, even as it markets biological acquisitions.

What to take from it

Corteva is not a new entrant but a carved-out incumbent—structured to operate at scale, acquire selectively, and separate high-margin seed IP from lower-margin pesticide logistics, all while navigating tightening regulation and consumer scrutiny.

Is it worth your time

Yes—if you are tracking how legacy agribusinesses restructure, pivot into biologicals, and manage regulatory and reputational risk while maintaining chemical portfolios.

Same desk · Companies4 of 325
9:49
SyngentaSwiss chemical-agricultural · 2000Syngenta is a global agricultural technology company headquartered in Basel, Switzerland, operating primarily in crop protection and seeds for farmers. It was founded in 2000 by the merger of the agrichemical businesses of Novartis and AstraZeneca. In 2004, Syngenta Seeds purchased Garst and Golden Harvest Seeds. In February 2016, ChemChina offered to purchase Syngenta for $43 billion, a deal Syngenta unanimously recommended to shareholders. In April 2017, U.S. and European antitrust authorities approved ChemChina's acquisition of Syngenta. To secure regulatory approval, ChemChina agreed to divest pesticide production of paraquat, abamectin, and chlorothalonil.
8:48
PfizerCharles Pfizer · 1849Pfizer’s origin story is not about curing disease — it is about solving chemical supply problems with fermentation. Its therapeutic dominance came decades after it mastered industrial microbiology under pressure.
9:10
Yara International2003Yara International is a Norwegian chemical company formed in 2004 from the de-merger of Hydro Agri from Norsk Hydro. It produces, distributes, and sells nitrogen-based mineral fertilizers and related industrial products, including phosphate, potash, complex, and specialty mineral fertilizers. It is listed on the Oslo Stock Exchange, headquartered in Oslo, and majority-controlled by the Norwegian government, which owns more than a third of its shares.
13:52
K+S1889K+S is Europe’s largest potash supplier. It mines, refines, and sells potash and other mineral fertilizers. Its DAX listing lasted eight years—but ended because its market capitalisation was inadequate. That gap matters more than its longevity or scale.
Up next in Business

Disruptive innovation

1995 · 10:03

Disruption isn’t what breaks markets—it’s what incumbents ignore until it’s too late.

Next brief →Back to Companies
10:03